Diagnostic and prognostic value of serum C-reactive protein for screening for HIV-associated tuberculosis

International Journal of Tuberculosis and Lung Disease

Volumn 17, Issue 5, 2013, Pages 636-643

  Lawn, Stephen D ^a,b   Kerkhoff, A D ^a,c   Vogt, M ^a   Wood, R ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

C reactive protein; Diagnosis; HIV; Screening; Tuberculosis

Indexed keywords

C REACTIVE PROTEIN; TUBERCULOSTATIC AGENT;

ADULT; AIDS RELATED COMPLEX; AREA UNDER THE CURVE; ARTICLE; BODY MASS; CD4 LYMPHOCYTE COUNT; CLINICAL ASSESSMENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; RELIABILITY; SCREENING TEST; SENSITIVITY AND SPECIFICITY; TUBERCULOSIS;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-RETROVIRAL AGENTS; BACTERIOLOGICAL TECHNIQUES; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CHI-SQUARE DISTRIBUTION; COINFECTION; FEMALE; HIV INFECTIONS; HUMANS; MALE; MASS SCREENING; MYCOBACTERIUM TUBERCULOSIS; ODDS RATIO; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS; SOUTH AFRICA; SPUTUM; TIME FACTORS; TUBERCULOSIS, PULMONARY; UP-REGULATION;

EID: 84876825140     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: 10.5588/ijtld.12.0811     Document Type: Article

References (30)

1. Lawn S D, Harries A D, Meintjes G, Getahun H, Havlir D V, Wood R. Reducing deaths from tuberculosis in antiretroviral treatment programmes in sub-Saharan Africa. AIDS 2012; 26: 2121-2133.
2. Harries A D, Zachariah R, Corbett E L, et al. The HIV-associated tuberculosis epidemic - When will we act? Lancet 2010; 375: 1906-1919.
3. Lawn S D, Wood R. Tuberculosis in antiretroviral treatment services in resource-limited settings: addressing the challenges of screening and diagnosis. J Infect Dis 2011; 204 (Suppl 4): S1159-S1167.
4. Boehme C C, Nabeta P, Hillemann D, et al. Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med 2010; 363: 1005-1015.
5. Lawn S D, Brooks S V, Kranzer K, et al. Screening for HIV-associated tuberculosis and rifampicin resistance before antiretroviral therapy using the Xpert MTB/RIF assay: a prospective study. PLoS Med 2011; 8: e1001067.
6. Lawn S D, Kerkhoff A D, Vogt M, Wood R. Diagnostic accuracy of a low-cost, urine antigen, point-of-care screening assay for HIV-associated pulmonary tuberculosis before antiretroviral therapy: a descriptive study. Lancet Infect Dis 2012; 12: 201-209.
7. Peter J G, Theron G, van Zyl-Smit R, et al. Diagnostic accuracy of a urine LAM strip-test for TB detection in HIV-infected hospitalised patients. Eur Respir J 2012; 7: e39966.
8. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999; 340: 448-454. (Pubitemid 29084777)
9. Engel M F, Paling F P, Hoepelman A I, van der Meer V, Oosterheert J J. Evaluating the evidence for the implementation of C-reactive protein measurement in adult patients with suspected lower respiratory tract infection in primary care: a systematic review. Fam Pract 2012; 29: 383-393.
10. Alvarez G G, Sabri E, Ling D, Cameron D W, Maartens G, Wilson D. A model to rule out smear-negative tuberculosis among symptomatic HIV patients using C-reactive protein. Int J Tuberc Lung Dis 2012; 16: 1247-1251.
11. Wilson D, Badri M, Maartens G. Performance of serum C-reactive protein as a screening test for smear-negative tuberculosis in an ambulatory high HIV prevalence population. PLoS ONE 2011; 6: e15248.
12. Sage E K, Noursadeghi M, Evans H E, et al. Prognostic value of C-reactive protein in HIV-infected patients with Pneumocystis jirovecii pneumonia. Int J STD AIDS 2010; 21: 288-292.
13. Drain P K, Kupka R, Msamanga G I, Urassa W, Mugusi F, Fawzi W W. C-reactive protein independently predicts HIV-related outcomes among women and children in a resource-poor setting. AIDS 2007; 21: 2067-2075. (Pubitemid 47462156)
14. Boulware D R, Hullsiek K H, Puronen C E, et al. Higher levels of CRP, D-dimer, IL-6, and hyaluronic acid before initiation of antiretroviral therapy (ART) are associated with increased risk of AIDS or death. J Infect Dis 2011; 203: 1637-1646.
15. Lawn S D, Myer L, Bekker L G, Wood R. Burden of tuberculosis in an antiretroviral treatment programme in sub-Saharan Africa: impact on treatment outcomes and implications for tuberculosis control. AIDS 2006; 20: 1605-1612. (Pubitemid 44162402)
16. Lawn S D, Kranzer K, Edwards D J, McNally M, Bekker L G, Wood R. Tuberculosis during the first year of antiretroviral therapy in a South African cohort using an intensive pretreatment screening strategy. AIDS 2010; 24: 1323-1328.
17. Getahun H, Kittikraisak W, Heilig C M, et al. Development of a standardized screening rule for tuberculosis in people living with HIV in resource-constrained settings: individual participant data meta-analysis of observational studies. PLoS Med 2011; 8: e1000391.
18. Lawn S D, Kerkhoff A D, Pahlana P, Vogt M, Wood R. Diagnostic yield of tuberculosis using sputum induction in HIV-positive patients before antiretroviral therapy. Int J Tuberc Lung Dis 2012; 16: 1354-1357.
19. Dawson R, Masuka P, Edwards D J, et al. Chest radiograph reading and recording system: evaluation for tuberculosis screening in patients with advanced HIV. Int J Tuberc Lung Dis 2010; 14: 52-58.
20. Lawn S D, Kerkhoff A D, Vogt M, Wood R. High diagnostic yield of tuberculosis from screening urine samples from HIV-infected patients with advanced immunodeficiency using the Xpert MTB/RIF assay. J Acquir Immune Defic Syndr 2012; 60: 289-294.
21. Bassett I V, Wang B, Chetty S, et al. Intensive tuberculosis screening for HIV-infected patients starting antiretroviral therapy in Durban, South Africa. Clin Infect Dis 2010; 51: 823-829.
22. Lawn S D, Wilkinson R J, Lipman M C, Wood R. Immune reconstitution and 'unmasking' of tuberculosis during antiretroviral therapy. Am J Respir Crit Care Med 2008; 177: 680-685. (Pubitemid 351490554)
23. Breen R A, Smith C J, Cropley I, Johnson M A, Lipman M C. Does immune reconstitution syndrome promote active tuberculosis in patients receiving highly active antiretroviral therapy? AIDS 2005; 19: 1201-1206. (Pubitemid 41059262)
24. Lawn S D, Wainwright H, Orrell C. Fatal unmasking tuberculosis immune reconstitution disease with bronchiolitis obliterans organizing pneumonia: the role of macrophages. AIDS 2009; 23: 143-145.
25. Lawn S D, Harries A D, Anglaret X, Myer L, Wood R. Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa. AIDS 2008; 22: 1897-1908.
26. Lawn S D, Kerkhoff A D, Vogt M, Ghebrekristos Y, Whitelaw A, Wood R. Characteristics and early outcomes of patients with Xpert MTB/RIF-negative pulmonary tuberculosis diagnosed during screening before antiretroviral therapy. Clin Infect Dis 2012; 54: 1071-1079.
27. Lawn S D, Wiktor S, Coulibaly D, Ackah A N, Lal R B. Serum C-reactive protein and detection of tuberculosis in persons co-infected with the human immunodeficiency virus. Trans R Soc Trop Med Hyg 2001; 95: 41-42. (Pubitemid 34202223)
28. Hosp M, Elliott A M, Raynes J G, et al. Neopterin, beta 2-microglobulin, and acute phase proteins in HIV-1-seropositive and -seronegative Zambian patients with tuberculosis. Lung 1997; 175: 265-275. (Pubitemid 27260315)
29. Martinson N A, Karstaedt A, Venter W D, et al. Causes of death in hospitalized adults with a pre-mortem diagnosis of tuberculosis: an autopsy study. AIDS 2007; 21: 2043-2050. (Pubitemid 47462153)
30. Lawn S D, Obeng J, Acheampong J W, Griffin G E. Resolution of the acute-phase response in West African patients receiving treatment for pulmonary tuberculosis. Int J Tuberc Lung Dis 2000; 4: 340-344. (Pubitemid 30194109)